$6.48 $0.21 per serving
Product analysis
CoQ10 100 mg is an affordable, simple option that may offer modest support for blood-vessel function, with mixed evidence for changes in blood pressure and blood fats.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The ubiquinone form is identified, which makes the preparation clear. Its name alone does not establish better absorption or benefit than other CoQ10 options.
Ingredient Transparency100
Both the amount and form are disclosed. That makes it straightforward to compare servings with other CoQ10 supplements.
Value For Money100
The serving offers good value for CoQ10. Its low relative cost suits someone seeking CoQ10 without additional active ingredients.
Customer Satisfaction92
Customer feedback is very positive. Tens of thousands of ratings provide an extensive base for judging satisfaction.
Product Focus70
One ingredient keeps the formula centred on CoQ10, with its clearest possible benefits involving blood-vessel function. Evidence for noticeable everyday energy benefits is more limited.
- Format
Softgel - Container
- 30 Softgel(s)
- Per serving
- $0.21
- Also available
CoQ10 100 mg$36.00- Customer rating
- 4.7 · 41,046 ratings
Goals
Impact
High effect
Coenzyme Q-10 · 100 mg
Coenzyme Q-10 has limited relevance to inflammation markers through its ubiquinone preparation. A small trial in statin-treated coronary disease found a difference in TNF-alpha, while CRP and IL-6 did not differ. This serving’s 100 mg is below the studied 300 mg daily exposure, so the finding does not establish a routine clinical benefit.
How this product is rated for Inflammation
Ingredient fit66
CoQ10 provide the main connection to this goal. The 100 mg serving is below the 300 mg daily ubiquinone exposure in the reviewed trial.
Goal fit
The formula centers on CoQ10, although its relevance extends beyond inflammation.
Dose adequacy
The 100 mg serving is below the 300 mg daily ubiquinone exposure in the reviewed trial.
Pathways13
The saved findings show a limited connection to oxidative and mitochondrial stress at this amount. No mechanism reaches the supplied coverage threshold, so broad coverage is not supported.
Depth
The saved findings show a limited connection to oxidative and mitochondrial stress at this amount.
Breadth
No mechanism reaches the supplied coverage threshold, so broad coverage is not supported.
Evidence93
CoQ10 has limited biomarker evidence from a specific clinical population, rather than established routine benefit.
Evidence strength
CoQ10 has limited biomarker evidence from a specific clinical population, rather than established routine benefit.
Studied preparation
The saved findings recognize the included preparation, but matching a preparation does not remove the limits of its clinical evidence.
Formulation logic100
The supplied findings identify no missing required partner or matched conflict. The included amounts pass the minimum comparison threshold, which does not prove clinical effectiveness.
Partner coverage
The included ingredients do not require an additional partner in the supplied findings; this does not demonstrate synergy.
Conflicts
No ingredient conflict was identified by the supplied checks; these checks do not establish comprehensive safety.
Effective doses
All ingredients retained in the amount-based findings pass the minimum comparison threshold; that threshold is not a proven effective dose.
Impact
Highest effect
Coenzyme Q-10 · 100 mg
CoQ10 has limited evidence for blood-pressure and lipid changes in selected adult populations, with mixed results. The 100 mg serving of ubiquinone receives partial amount recognition against conventional oral CoQ10 exposure. Those findings do not establish heart-disease treatment or prevention, and the identified form does not by itself demonstrate superior absorption or benefit.
How this product is rated for Heart Health
Ingredient fit86
CoQ10 is the sole credited active, focused on a limited vascular connection.
Goal fit
CoQ10 is the sole credited active, focused on a limited vascular connection.
Dose adequacy
The 100 mg serving receives partial recognition against the conventional oral CoQ10 exposure reference.
Pathways53
The main covered route concerns blood-vessel lining function.
Depth
The main covered route concerns blood-vessel lining function.
Breadth
One main route reaches the saved coverage threshold; the contribution is concentrated rather than broad.
Evidence98
CoQ10 leads the saved evidence finding, with mixed blood-pressure findings in selected populations.
Evidence strength
CoQ10 leads the saved evidence finding, with mixed blood-pressure findings in selected populations.
Studied preparation
Declared conventional oral CoQ10 active mass matches the saved preparation branch; no delivery advantage is established.
Formulation logic100
The credited ingredients do not require an additional partner, and no configured conflicts were identified.
Partner coverage
The credited ingredients can contribute without an additional required partner.
Conflicts
No configured conflict was identified; this does not establish overall safety.
Effective doses
All credited ingredients meet the saved minimum amount threshold; that threshold is not a proven effective dose.
Impact
Moderate effect
Coenzyme Q-10 · 100 mg
CoQ10 at 100 mg supports normal mitochondrial energy production and antioxidant processes. Limited improvements in skin wrinkles and smoothness were reported with a specific water-soluble preparation; those results cannot be assumed for every CoQ10 material or taken as evidence of longer life.
How this product is rated for Longevity
Ingredient fit73
The relevant ingredient gives the formula a clear focus on the reviewed aging-related functions. Ingredient amounts provide a partial match to the saved exposure comparisons.
Goal fit
The relevant ingredient gives the formula a clear focus on the reviewed aging-related functions.
Dose adequacy
Ingredient amounts provide a partial match to the saved exposure comparisons.
Pathways10
The leading mechanism in the saved assessment is mitochondrial energy production. None of the three target mechanisms reaches the saved coverage threshold.
Depth
The leading mechanism in the saved assessment is mitochondrial energy production.
Breadth
None of the three target mechanisms reaches the saved coverage threshold.
Evidence30
Coenzyme Q-10 leads the saved evidence finding; that comparison does not establish longer life. Preparation matching is limited for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; that comparison does not establish longer life.
Studied preparation
Preparation matching is limited for Coenzyme Q-10.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was found in the supplied assessment. 1 of 1 counted ingredients reach the saved minimum amount criterion.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
1 of 1 counted ingredients reach the saved minimum amount criterion.
Impact
High effect
Coenzyme Q-10 · 100 mg
CoQ10 in the ubiquinone form has limited support for fatigue relief, distinct from an immediate alertness effect. Its role in cellular energy production does not by itself prove a noticeable energy boost, and clinical disease findings do not transfer to routine healthy use. The serving falls short of the full saved amount comparison.
How this product is rated for Energy
Ingredient fit73
Coenzyme Q-10 anchors the recognized ingredient fit, with declared amounts partly meeting the saved comparisons.
Goal fit
Coenzyme Q-10 is central to the product’s recognized energy connection, although the product is also linked to other goals.
Dose adequacy
The declared amounts partly meet the saved comparisons, limiting the size of the recognized contribution.
Pathways17
The saved coverage is concentrated in mitochondrial energy production.
Depth
The strongest saved coverage concerns mitochondrial energy production; this does not independently prove a noticeable energy benefit.
Breadth
No energy pathway reaches the saved breadth threshold.
Evidence84
Coenzyme Q-10 leads the recognized evidence, but the supplied context limits how broadly its findings apply.
Evidence strength
Coenzyme Q-10 supplies the strongest recognized evidence here, subject to the population and application limits described for it.
Studied preparation
The saved findings accept the qualifying preparations; this does not establish form superiority.
Formulation logic100
No required partner is missing, and no configured sedative conflict is present. The recognized amounts reach the saved minimum comparison.
Partner coverage
The recognized ingredients have no missing required partner for their assigned contributions.
Conflicts
No configured sedative conflict applies: valerian, kava, qualifying tryptophan and melatonin are absent.
Effective doses
All recognized ingredients reach the saved minimum amount comparison; that threshold is not proof of a clinical energy effect.
Impact
Highest effect
Coenzyme Q-10 · 100 mg
CoQ10 may support blood-vessel lining function and some blood-pressure or lipid markers in people with dyslipidemia. This serving supplies 100 mg of ubiquinone, giving substantial but partial comparison with the supplied preparation amount. These findings do not establish prevention of cardiovascular events or superiority of one CoQ10 form.
How this product is rated for Cardiovascular Support
Ingredient fit86
CoQ10 is the focused cardiovascular ingredient, although the product is linked to several other goals. The CoQ10 serving provides substantial but partial fulfillment of the supplied preparation comparison amount.
Goal fit
CoQ10 is the focused cardiovascular ingredient, although the product is linked to several other goals.
Dose adequacy
The CoQ10 serving provides substantial but partial fulfillment of the supplied preparation comparison amount.
Pathways53
The main substantial area is blood-vessel lining function; other evaluated cardiovascular areas have little or no coverage.
Depth
CoQ10 provides the strongest connection to blood-vessel lining function.
Breadth
The main substantial area is blood-vessel lining function; other evaluated cardiovascular areas have little or no coverage.
Evidence88
CoQ10 has limited clinical support for vascular, blood-pressure or lipid markers in dyslipidemia, without establishing event prevention.
Evidence strength
CoQ10 has limited clinical support for vascular, blood-pressure or lipid markers in dyslipidemia, without establishing event prevention.
Studied preparation
The saved finding accepts the preparations of the ingredients with usable comparison amounts; this does not establish that the complete formula reproduces a studied regimen.
Formulation logic100
All quantified contributing ingredients meet the retained minimum amount threshold, which does not establish a proven effective daily regimen. No configured conflict was identified.
Partner coverage
The contributing ingredients can retain their individual roles without an absent required partner.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All quantified contributing ingredients meet the retained minimum amount threshold, which does not establish a proven effective daily regimen.
Impact
High effect
Coenzyme Q-10 · 100 mg
CoQ10 participates in mitochondrial electron transport, an important part of normal cellular energy handling. The 100 mg per serving receives partial amount recognition in the saved findings. The supplied metabolic-control studies do not demonstrate that this serving raises whole-body energy expenditure, and they cannot establish routine benefits for adequately nourished adults.
How this product is rated for Metabolism Support
Ingredient fit73
CoQ10 is recognized at a partial amount relative to the configured reference exposure.
Goal fit
The credited ingredients give the formula a clear connection to the reviewed metabolic functions.
Dose adequacy
The CoQ10 serving receives partial amount recognition relative to the configured reference exposure.
Pathways17
CoQ10 supplies a partial mitochondrial-energy finding.
Depth
CoQ10 supplies a partial mitochondrial-energy finding.
Breadth
No pathway reaches the coverage threshold in the saved findings.
Evidence75
The CoQ10 evidence does not directly establish a routine metabolic-rate increase.
Evidence strength
The CoQ10 evidence does not directly establish a routine metabolic-rate increase.
Studied preparation
The saved findings recognize the evaluated preparation, within the ingredient-specific limits of the supplied human evidence.
Formulation logic100
The recognized ingredients have their required partners or work independently, and no matched formulation conflict appears.
Partner coverage
Recognized ingredients have any required partner or work independently; no additional combination benefit is established.
Conflicts
No matched formulation conflict appears in the supplied findings.
Effective doses
All included ingredients meet this amount threshold; it is not a proven minimum effective dose or evidence of extra metabolic benefit.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q-10 (Ubiquinone) | 100 mg |
Coenzyme Q-10 (Ubiquinone) · 100 mg OverallScore72
A serving provides 100 mg of CoQ10 as ubiquinone. The evaluated cost is about $0.22 per 100 mg of CoQ10, a relatively low price in the comparison.
How this ingredient is rated
Active Ingredient Quality & Bioavailability48
The evaluation identifies the CoQ10 as ubiquinone. No configured absorption enhancer is recorded.
Molecular Form: Ubiquinol vs. Ubiquinone
The evaluation identifies ubiquinone, a form the body converts to ubiquinol.
Formulation & Absorption Enhancers
The saved evaluation records no configured special delivery technology or black pepper extract as an absorption enhancer.
Dose, Safety & Label Transparency83
The CoQ10 amount is stated as 100 mg per serving.
Clinical Dosage Alignment
The recorded amount is 100 mg of CoQ10 per serving.
Label Transparency & Fillers
The CoQ10 amount is stated, and the checked other ingredients contain no additives or fillers flagged by the evaluation.
Value100
The evaluated cost is about $0.22 per 100 mg of CoQ10, a relatively low price in the comparison.
Price Per Effective Serving
The evaluated cost is about $0.22 per 100 mg of CoQ10, a relatively low price in the comparison.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.